A continuación encontrará estudios de casos, seminarios web, blogs y comunicados de prensa en los que compartimos información valiosa sobre los ensayos clínicos descentralizados.
ObvioHealth and 1nHealth announce today a joint initiative to smooth the transition to hybrid and decentralized clinical research. The initiative focuses on supporting clinical trials that may be struggling due to suboptimal protocol design, imprecise recruitment strategies, maladapted technology options or ailing site teams. According to clinicaltrials.gov, there are about 1,600 suspended trials at present.
How do increasingly prevalent DCT methods fit into the existing clinical trial ecosystem? In short: There are complexities. Many eClinical platforms still lack key capabilities, which often require complex integrations with third-party solutions.
ObvioHealth, a leading global Virtual Research Organization (VRO) delivering end-to-end decentralized clinical trial solutions, announces it has completed the first fully virtual urogynecology study in partnership with trial sponsor, Renovia, Inc. The trial validated the efficacy of Renovia’s leva® Pelvic Health System on women’s incontinence, a health concern that affects 62% of U.S. adult women.
Combining the ease of ePRO with expert rating—patient convenience with the objectivity of experts—facilitates more accurate data collection.
The rapid expansion of the clinical research market in the Asia-Pacific (APAC) region has opened up significant prospects for carrying out decentralized clinical trials there.